Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Healthcare IT » HHE-6640817
  • Global Cognitive Assessment and Training in Healthcare Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • Publish: July 2017 | Report Code: HHE-6640817

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

A cognitive assessment refers to an examination to determine someone’s level of cognitive function. To determine the cognitive injury, mental health professional neurologists or education professional administers cognitive assessment test. Cognitive assessment and training is a proper assessment of one’s psychological purposes and speed of information processing. Cognitive assessment method of assessment aids an individual in defining, assessing and focusing on individual requirements more proficiently. Cognitive injury can arise in late adulthood or early childhood. There are numerous disorders for it, such as irreversible or reversible condition. Primary causes may comprise prenatal drug exposure, malnutrition, chromosome abnormalities and genetic syndromes. The brain holds its neuroplasticity till late adulthood; consequently, there has been a rising demand for cognitive assessment and training. The global cognitive assessment and training in healthcare is growing with a CAGR (Compound Annual Growth Rate) of around 33.8% during the forecast period (2016-2023). Advancement in technology is trending in the global cognitive assessment and training in healthcare market. For example; Quest diagnostics a clinical  laboratory service provider in the year 2017 launched an iPad app CogniSense™, a cognitive assessment test which permits healthcare providers to quickly and objectively access a patient’s cognitive health. The major driving factor of the global cognitive assessment and training in healthcare are rising aging population, brain fitness awareness, and development in technology.

The rising Alzheimer cases majorly driven the global cognitive assessment and training in healthcare, as the number of cases of dementia is rising across the world, a dementia is a broad category of brain diseases. According to Alzheimer’s disease international organization, it is estimated that in the world around 46.8 million people were living with dementia in the year 2015 and this number is expected  to be adjacent to 50 million people in the year 2017. This number expects to be almost double in every 20 years, which is anticipated to be around 75 million in the year 2030 and 131.5 million in the year 2050. Considerable increase is expected to be in emerging countries. In the year 2016 around 58% of people with dementia live in middle and low-income nations, nevertheless by the year 2050 this will increase to around 68%.  It is estimated that around 9.9 million new cases of dementia every year across the globe, and implying one new case in every 3.2 seconds. The total estimated cost across the world of dementia is around $818 billion in the year 2015 which is around 1.09% of global. The global cost of dementia by the year 2018 is expected to be more than $ trillion.  

Source: OBRC Analysis.

The report on global cognitive assessment and training in healthcare market includes assessment type, component and applications.

Assessment type is segmented into:

  • Pen and paper-assessment
  • Hosted assessment
  • Biometrics assessment




Component is segmented into:

  • Solution
  • Services



Application segment is segmented into:

  • Clinical trials
  • Screening and diagnostics
  • Brain training
  • Academic research
  • Others






The report scope is widely categorized on the basis of its assessment type which include pen and paper-assessment, hosted assessment, biometrics assessment. Moreover, the market revenue estimates and forecast includes solution and services.

The global cognitive assessment and training in healthcare report has been geographically segmented in:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





On the basis of the geography, North America is projected to have the major market share and dominate the market during in the year 2016. As the large number of vendors offers cognitive assessment and training in healthcare, the united states in the global cognitive assessment and training in healthcare market holds most of market share in terms of revenue and the adoption in the North America region, owing to rising increased awareness among population and increasing demand for enhancing neuroplasticity of brain. Moreover, according to the Alzheimer's Association organization, in America Alzheimer's disease is growing with a fast pace, it is estimated that around 5.5 million Americans are living with Alzheimer dementia in the year 2017. In the United States Alzheimer's disease is the sixth-leading reason of death. It is the fifth-leading source of death among those age 65 and older or above and a foremost cause of poor health and disability. 

Global cognitive assessment and training in healthcare market report covers segmentation analysis of assessment type, component and application. Report further covers segments of assessment type which includes pen and paper-assessment, hosted assessment and biometrics assessment. Pen and paper based assessment is anticipated to contribute the maximum revenue among other assessment type methods during the forecast period. Pen- and paper-based assessment is a conventional method for determining the cognitive behaviour of an individual and remains mainly the standard for the assessment of cognitive weakening.

 The major market players of the Global cognitive assessment and training in healthcare market are:

  • BRACKET
  • CAMBRIDGE COGNITION LTD
  • COGSTATE LTD
  • MEDAVANTE INC 8
  • NEUROCOG TRIALS
  • PEARSON ASSESSMENT
  • QUEST DIAGNOSTICS
  • Others









These companies using various strategies such as merger & acquisition, collaboration, partnership and product launch. Whereas, product launch is the key strategy adopted by the companies in the Global cognitive assessment and training in healthcare market.

For example: MedAvante Inc., which offers enabled solutions in clinical trials in the year 2015 releases novel software for the Virgil investigative study platform. Virgil platform is advanced technology with more advantages for clinical studies as compare to any other technology solution, also employed in the treatments for psychiatric disorders and Alzheimer's disease.

The report covers detailed analysis of companies which comprises overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in cognitive assessment and training in healthcare.

Key reason to buy the report:

  • The report includes market estimation, forecast and analysis for the year 2016-2023.
  • Report includes detailed analysis of different segments such as assessment type, component and applications of Global cognitive assessment and training in healthcare market
  • Identify and understand the strength, opportunities, challenges and threat of the Global cognitive assessment and training in healthcare market.
  • Covers details analysis of Porters 5 force model and other strategic models and also covers revenues, market share analysis, competitive landscape analysis of major players of Global cognitive assessment and training in healthcare market.
  • Detailed analysis of various the regulatory policies which are affecting the Global cognitive assessment and training in healthcare market.






How we are different from others:

At Occam’s we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global cognitive assessment and training in healthcare market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the Global cognitive assessment and training in healthcare market, with giving extensive SCOT analysis of key companies. 

Key findings of the global cognitive assessment and training in healthcare market.

  • Rising Alzheimer cases in the global cognitive assessment and training in healthcare market.
  • North America held highest revenue share in 2016.
  • Pen and paper based assessment segment held the large revenue share in 2016.
  • Acquisition is the key strategy adopted by players of global cognitive assessment and training in healthcare market.  
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION AND SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. PRICING ANALYSIS
2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES AND ANALYSIS
2.8.2. MARKET SHARE & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. RISING AGING POPULATION
3.1.2. BRAIN FITNESS AWARENESS
3.1.3. DEVELOPMENT IN TECHNOLOGY
3.2. MARKET RESTRAINTS
3.2.1. TIME RESTRAINT IN EMERGING CLINICALLY VALIDATED BRAIN FITNESS SOFTWARE
3.2.2. STRINGENT GOVERNMENT REGULATIONS 
1.1. MARKET OPPORTUNITIES
1.1.1. INCREASING USE OF MODERN COGNITIVE ASSESSMENT AND TRAINING TOOLS
1.1.2. INCREASE IN DEMAND FOR IMPROVED BRAIN FITNESS
1.2.  MARKET CHALLENGES 
1.2.1. SUITABILITY OF THE COGNITIVE ASSESSMENT PROCESS
1.2.2. AWARENESS ABOUT BRAIN FITNESS
 
2. MARKET SEGMENTATION 
2.1. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CAREMARKET BY ASSESSMENT TYPE
2.1.1. MARKET DEFINITION AND SCOPE
2.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
2.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
2.1.4. OPPORTUNITY MATRIX
2.1.5. MARKET SEGMENTATION 
2.1.5.1. PEN AND PAPER-ASSESSMENT
2.1.5.1.1. APPLICATIONS
2.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
2.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
2.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
2.1.5.1.5. KEY CONCLUSIONS
2.1.5.2. HOSTED ASSESSMENT
2.1.5.2.1. APPLICATIONS
2.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
2.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
2.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
2.1.5.2.5. KEY CONCLUSIONS
2.1.5.3. BIOMETRICS ASSESSMENT
2.1.5.3.1. APPLICATIONS
2.1.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
2.1.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
2.1.5.3.4. TOP PLAYERS & KEY PRODUCTS
2.1.5.3.5. KEY CONCLUSIONS
2.2. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CAREMARKET BY BY COMPONENT
2.2.1. MARKET DEFINITION AND SCOPE
2.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
2.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
2.2.4. OPPORTUNITY MATRIX
2.2.5. MARKET SEGMENTATION 
2.2.5.1. SOLUTION
2.2.5.1.1. APPLICATIONS
2.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
2.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
2.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
2.2.5.1.5. KEY CONCLUSIONS
2.2.5.1.6. SUB SEGMENT
2.2.5.1.6.1. ASSESSMENT
2.2.5.1.6.2. DATA MANAGEMENT
2.2.5.1.6.3. DATA MANAGEMENT
2.2.5.1.6.4. DATA ANALYSIS AND REPORTING
2.2.5.1.6.5. OTHERS 
2.2.5.2. SERVICES
2.2.5.2.1. APPLICATIONS
2.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
2.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
2.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
2.2.5.2.5. KEY CONCLUSIONS
2.2.5.2.6. SUB SEGMENT
2.2.5.2.6.1. TRAINING AND SUPPORT
2.2.5.2.6.2. CONSULTING
2.3. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CAREMARKET BY APPLICATION
2.3.1. MARKET DEFINITION AND SCOPE
2.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
2.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
2.3.4. OPPORTUNITY MATRIX
2.3.5. MARKET SEGMENTATION 
2.3.5.1. CLINICAL TRIALS
2.3.5.1.1. APPLICATIONS
2.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
2.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
2.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
2.3.5.1.5. KEY CONCLUSIONS
2.3.5.2. SCREENING AND DIAGNOSTICS
2.3.5.2.1. APPLICATIONS
2.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
2.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
2.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
2.3.5.2.5. KEY CONCLUSIONS
2.3.5.3. BRAIN TRAINING
2.3.5.3.1. APPLICATIONS
2.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
2.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
2.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
2.3.5.3.5. KEY CONCLUSIONS
2.3.5.4. ACADEMIC RESEARCH
2.3.5.4.1. APPLICATIONS
2.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
2.3.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
2.3.5.4.4. TOP PLAYERS & KEY PRODUCTS
2.3.5.4.5. KEY CONCLUSIONS
2.3.5.5. OTHERS
2.3.5.5.1. APPLICATIONS
2.3.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
2.3.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
2.3.5.5.4. TOP PLAYERS & KEY PRODUCTS
2.3.5.5.5. KEY CONCLUSIONS
 
3. COMPETITIVE LANDSCAPE
3.1. KEY STRATEGIES
3.1.1. LIST OF MERGERS & ACQUISITION 
3.1.2. LIST OF JOINT VENTURES
3.1.3. LIST OF PRODUCT LAUNCHES
3.1.4. LIST OF PARTNERSHIPS
3.2. TOP 10 COMPANY ANALYSIS
 
4. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY REGION 
4.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3. OPPORTUNITY MATRIX
4.4. GEOGRAPHIC SEGMENTATION
4.4.1. NORTH AMERICA
4.4.1.1. INDUSTRY APPLICATION ANALYSIS
4.4.1.2. TOP COUNTRY ANALYSIS
4.4.1.2.1. U.S. 
4.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
4.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
4.4.1.2.1.3. KEY CONCLUSIONS
4.4.1.2.2. CANADA
4.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
4.4.1.2.2.3. KEY CONCLUSIONS
4.4.2. EUROPE
4.4.2.1. INDUSTRY APPLICATION ANALYSIS
4.4.2.2. TOP COUNTRY ANALYSIS
4.4.2.2.1. UK
4.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
4.4.2.2.1.3. KEY CONCLUSIONS
4.4.2.2.2. FRANCE
4.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
4.4.2.2.2.3. KEY CONCLUSIONS
4.4.2.2.3. GERMANY
4.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
4.4.2.2.3.3. KEY CONCLUSIONS
4.4.2.2.4. SPAIN
4.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
4.4.2.2.4.3. KEY CONCLUSIONS
4.4.2.2.5. ITALY 
4.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
4.4.2.2.5.3. KEY CONCLUSIONS
4.4.2.2.6. REST OF EUROPE
4.4.2.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.2.2.6.2. TOP PLAYERS & KEY PRODUCTS
4.4.2.2.6.3. KEY CONCLUSIONS
4.4.3. ASIA PACIFIC
4.4.3.1. INDUSTRY APPLICATION ANALYSIS
4.4.3.2. TOP COUNTRY ANALYSIS
4.4.3.2.1. CHINA
4.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
4.4.3.2.1.3. KEY CONCLUSIONS
4.4.3.2.2. INDIA
4.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
4.4.3.2.2.3. KEY CONCLUSIONS
4.4.3.2.3. JAPAN
4.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
4.4.3.2.3.3. KEY CONCLUSIONS
4.4.3.2.4. SOUTH KOREA
4.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
4.4.3.2.4.3. KEY CONCLUSIONS
4.4.3.2.5. AUSTRALIA
4.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
4.4.3.2.5.3. KEY CONCLUSIONS
4.4.3.2.6. REST OF ASIA PACIFIC
4.4.3.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.3.2.6.2. TOP PLAYERS & KEY PRODUCTS
4.4.3.2.6.3. KEY CONCLUSIONS
4.4.4. ROW
4.4.4.1. INDUSTRY APPLICATION ANALYSIS
4.4.4.2. TOP COUNTRY ANALYSIS
4.4.4.2.1. LATIN AMERICA
4.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
4.4.4.2.1.3. KEY CONCLUSIONS
4.4.4.2.2. MIDDLE EAST & AFRICA 
4.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
4.4.4.2.2.3. KEY CONCLUSIONS
 
5. COMPANY PROFILES
5.1. BRACKET
5.1.1. OVERVIEW
5.1.2. PRODUCT PORTFOLIO
5.1.3. KEY INNOVATION/FOCUS SECTOR
5.1.4. STRATEGIC INITIATIVES 
5.1.5. SCOT ANALYSIS
5.1.6. STRATEGIC ANALYSIS
5.2.  BRAIN RESOURCE COMPANY.
5.2.1. OVERVIEW
5.2.2. PRODUCT PORTFOLIO
5.2.3. KEY INNOVATION/FOCUS SECTOR
5.2.4. STRATEGIC INITIATIVES 
5.2.5. SCOT ANALYSIS 
5.2.6. STRATEGIC ANALYSIS
5.3. CAMBRIDGE COGNITION LTD
5.3.1. OVERVIEW
5.3.2. PRODUCT PORTFOLIO
5.3.3. KEY INNOVATION/FOCUS SECTOR
5.3.4. STRATEGIC INITIATIVES 
5.3.5. SCOT ANALYSIS
5.3.6. STRATEGIC ANALYSIS
5.4. COGSTATE LTD.
5.4.1. OVERVIEW
5.4.2. PRODUCT PORTFOLIO
5.4.3. KEY INNOVATION/FOCUS SECTOR
5.4.4. STRATEGIC INITIATIVES 
5.4.5. SCOT ANALYSIS
5.4.6. STRATEGIC ANALYSIS
5.5. COGNIFIT
5.5.1. OVERVIEW
5.5.2. PRODUCT PORTFOLIO
5.5.3. KEY INNOVATION/FOCUS SECTOR
5.5.4. STRATEGIC INITIATIVES 
5.5.5. SCOT ANALYSIS
5.5.6. STRATEGIC ANALYSIS
5.6. ERT CLINICAL
5.6.1. OVERVIEW
5.6.2. PRODUCT PORTFOLIO
5.6.3. KEY INNOVATION/FOCUS SECTOR
5.6.4. STRATEGIC INITIATIVES 
5.6.5. SCOT ANALYSIS
5.6.6. STRATEGIC ANALYSIS
5.7. LEARNINGRX
5.7.1. OVERVIEW
5.7.2. PRODUCT PORTFOLIO
5.7.3. KEY INNOVATION/FOCUS SECTOR
5.7.4. STRATEGIC INITIATIVES 
5.7.5. SCOT ANALYSIS
5.7.6. STRATEGIC ANALYSIS
5.8. MOCA MONTREAL 
5.8.1. OVERVIEW
5.8.2. PRODUCT PORTFOLIO
5.8.3. KEY INNOVATION/FOCUS SECTOR
5.8.4. STRATEGIC INITIATIVES 
5.8.5. SCOT ANALYSIS
5.8.6. STRATEGIC ANALYSIS
5.9. MEDAVANTE INC 
5.9.1. OVERVIEW
5.9.2. PRODUCT PORTFOLIO
5.9.3. KEY INNOVATION/FOCUS SECTOR
5.9.4. STRATEGIC INITIATIVES 
5.9.5. SCOT ANALYSIS
5.9.6. STRATEGIC ANALYSIS
5.10. NEUROCOG TRIALS. 
5.10.1. OVERVIEW
5.10.2. PRODUCT PORTFOLIO
5.10.3. KEY INNOVATION/FOCUS SECTOR
5.10.4. STRATEGIC INITIATIVES
5.10.5. SCOT ANALYSIS
5.10.6. STRATEGIC ANALYSIS 
5.11. NEUROSKY. 
5.11.1. OVERVIEW
5.11.2. PRODUCT PORTFOLIO
5.11.3. KEY INNOVATION/FOCUS SECTOR
5.11.4. STRATEGIC INITIATIVES
5.11.5. SCOT ANALYSIS
5.11.6. STRATEGIC ANALYSIS 
5.12. PROPHASE, LLC. 
5.12.1. OVERVIEW
5.12.2. PRODUCT PORTFOLIO
5.12.3. KEY INNOVATION/FOCUS SECTOR
5.12.4. STRATEGIC INITIATIVES 
5.12.5. SCOT ANALYSIS
5.12.6. STRATEGIC ANALYSIS
5.13. PEARSON ASSESSMENT
5.13.1. OVERVIEW
5.13.2. PRODUCT PORTFOLIO
5.13.3. KEY INNOVATION/FOCUS SECTOR
5.13.4. STRATEGIC INITIATIVES 
5.13.5. SCOT ANALYSIS
5.13.6. STRATEGIC ANALYSIS
5.14. QUEST DIAGNOSTICS 
5.14.1. OVERVIEW
5.14.2. PRODUCT PORTFOLIO
5.14.3. KEY INNOVATION/FOCUS SECTOR
5.14.4. STRATEGIC INITIATIVES 
5.14.5. SCOT ANALYSIS 
5.14.6. STRATEGIC ANALYSIS
5.15. SAVONIX
5.15.1. OVERVIEW
5.15.2. PRODUCT PORTFOLIO
5.15.3. KEY INNOVATION/FOCUS SECTOR
5.15.4. STRATEGIC INITIATIVES 
5.15.5. SCOT ANALYSIS 
5.15.6. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CAREMARKET BY ASSESSMENT TYPE 2014-2023 ($ MILLION)
2. GLOBAL PEN AND PAPER-ASSESSMENT BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL HOSTED ASSESSMENT BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL BIOMETRICS ASSESSMENT BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CAREMARKET BY COMPONENT 2014-2023 ($ MILLION)
6. GLOBAL SOLUTION BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL SERVICES BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CAREMARKET BY APPLICATION 2014-2023 ($ MILLION)
9. GLOBAL BANKING, FINANCIAL SERVICES, AND INSURANCE BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL CLINICAL TRIALSBY GEOGRAPHY 2014-2023 ($ MILLION)
11. GLOBAL SCREENING AND DIAGNOSTICS BY GEOGRAPHY 2014-2023 ($ MILLION)
12. GLOBAL BRAIN TRAINING BY GEOGRAPHY 2014-2023 ($ MILLION)
13. GLOBAL ACADEMIC RESEARCH BY GEOGRAPHY 2014-2023 ($ MILLION)
14. GLOBAL OTHERS BY GEOGRAPHY 2014-2023 ($ MILLION)
15. NORTH AMERICA COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($ MILLION)
16. EUROPE COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($ MILLION)
17. ASIA PACIFIC COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($ MILLION)
18. REST OF THE WORLD COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
 
1. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY PEN AND PAPER-ASSESSMENT 2014-2023 ($ MILLION)
2. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY HOSTED ASSESSMENT 2014-2023 ($ MILLION)
3. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY BIOMETRICS ASSESSMENT 2014-2023 ($ MILLION)
4. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY SOLUTION 2014-2023 ($ MILLION)
5. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY SERVICES 2014-2023 ($ MILLION)
6. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY CLINICAL TRIALS 2014-2023 ($ MILLION)
7. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY SCREENING AND DIAGNOSTICS 2014-2023 ($ MILLION)
8. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY BRAIN TRAINING 2014-2023 ($ MILLION)
9. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY ACADEMIC RESEARCH 2014-2023 ($ MILLION)
10. GLOBAL COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE MARKET BY OTHERS 2014-2023 ($ MILLION)
11. UNITED STATES (U.S.) COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
12. CANADA COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
13. UNITED KINGDOM (UK) COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
14. FRANCE COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
15. GERMANY COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
16. SPAIN COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
17. ITALY COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
18. ROE COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
19. INDIA COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
20. CHINA COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
21. JAPAN COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
22. KOREA COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
23. AUSTRALIA COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
24. ROW APAC COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
25. LATIN AMERICA COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)
26. MENA COGNITIVE ASSESSMENT AND TRAINING IN HEALTH CARE SERVER MARKET 2014-2023 ($MILLION)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample


UPCOMING REPORTS

No upcoming reports available under this subcategory.
credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: [email protected]

 

 

Go To Top
viewthroughconversion